Market cap
$27 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -35.00 | -77.38 | -61.41 |
| EBIT | 2.14 | -5.43 | -14.47 | -236.18 | -295.99 |
| Net Profit | -0.13 | -7.54 | -17.91 | -240.12 | -267.58 |
| EPS | 30.68 | 28.86 | 17.03 | -39.63 | -229.91 |
| Book Value | -- | -- | -74.81 | -46.89 | -36.62 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Jun-22 | Jun-21 |
| EBIT-Margin
| -11,314.71 | -6,807.31 | -21,080.92 | -20,390.46 | -11,686.20 |
| Net Margin
| -1,279.75 | -456.12 | -21,610.46 | -- | -- |
| Return on equity
| -84.89 | -55.35 | -217.20 | -119.60 | -73.75 |
| Return on Capital
| -67.46 | -44.90 | -- | -84.99 | -60.21 |
| Return on Assets
| -56.59 | -37.53 | -65.01 | -71.20 | -50.89 |
| Debt to Equity (x)
| -- | -- | 0.39 | 0.76 | 0.29 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
--
|
-84.99
|
-60.21
|
-57.18
|
-2.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-217.20
Lower than Peers by 190.88
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
-217.20
|
-119.60
|
-73.75
|
-61.30
|
-2.26
|
|
Peer Median
|
-26.31
|
--
|
--
|
--
|
--
|
ROA
-65.01
Lower than Peers by 52.05
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
-65.01
|
-71.20
|
-50.89
|
-47.67
|
-1.90
|
|
Peer Median
|
-12.96
|
--
|
--
|
--
|
--
|
EBIT Margin
-21,080.92
Lower than Peers by 21,021.22
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
-21,080.92
|
-20,390.46
|
-11,686.20
|
-1,867.47
|
-4.63
|
|
Peer Median
|
-59.70
|
--
|
--
|
--
|
--
|
Net Margin
-21,610.46
Lower than Peers by 21,539.40
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
-21,610.46
|
-21,213.23
|
-11,565.80
|
-1,279.75
|
-4.55
|
|
Peer Median
|
-71.06
|
--
|
--
|
--
|
--
|
Cash Profit Margin
-0.01
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
-0.01
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-35.00
Lower than Peers by 55.56
Year on year growth in net sales
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
-35.00
|
-0.35
|
-0.80
|
-0.94
|
0.72
|
|
Peer Median
|
20.56
|
--
|
--
|
--
|
--
|
EBIT Growth
-14.47
Lower than Peers by 29.67
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
-14.47
|
-13.41
|
-27.55
|
-2,273.52
|
90.91
|
|
Peer Median
|
15.20
|
--
|
--
|
--
|
--
|
Net Profit Growth
-17.91
Lower than Peers by 25.77
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
-17.91
|
-19.22
|
-26.01
|
-2,187.74
|
90.58
|
|
Peer Median
|
7.86
|
--
|
--
|
--
|
--
|
EPS Growth
17.03
Lower than Peers by 13.42
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
17.03
|
0.13
|
0.20
|
-18.61
|
0.91
|
|
Peer Median
|
30.45
|
--
|
--
|
--
|
--
|
Book Value Growth
-83.21
Lower than Peers by 84.46
Year on year growth in book value per share
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
-83.21
|
--
|
--
|
--
|
--
|
|
Peer Median
|
1.25
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.39
--
Total debt / Net worth
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
0.39
|
0.76
|
0.29
|
0.15
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
--
|
0.36
|
0.04
|
0.02
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.40
Lower than Peers by 2.08
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
1.40
|
1.97
|
5.56
|
6.40
|
9.01
|
|
Peer Median
|
3.48
|
--
|
--
|
--
|
--
|
Quick Ratio
1.40
Lower than Peers by 1.89
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
1.40
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3.29
|
--
|
--
|
--
|
--
|
Interest Coverage
-25.29
Lower than Peers by 23.78
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
-25.29
|
-24.78
|
-38.80
|
--
|
--
|
|
Peer Median
|
-1.51
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
--
|
--
|
--
|
--
|
0.03
|
|
Peer Median
|
24.33
|
--
|
--
|
--
|
--
|
Asset Turnover
0.00
Lower than Peers by 0.23
Sales / Average Total Assets
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
0.00
|
0.00
|
0.00
|
0.03
|
0.40
|
|
Peer Median
|
0.23
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
--
|
--
|
--
|
0.97
|
0.98
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
--
|
--
|
--
|
--
|
30.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
--
|
--
|
--
|
--
|
-29.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
--
|
-0.50
|
-2.23
|
-2.54
|
-34.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
1.51
Lower than Peers by 3.45
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
1.51
|
1.18
|
1.50
|
1.64
|
0.87
|
|
Peer Median
|
4.96
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.19
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
-0.19
|
-0.17
|
-0.82
|
-1.05
|
20.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
27
Lower than Peers by 57
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Applied Genetic (AGTC)
|
27
|
--
|
--
|
--
|
--
|
|
Peer Median
|
83
|
--
|
--
|
--
|
--
|